165 related articles for article (PubMed ID: 27891190)
1. Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.
Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Drewes AM; Pedersen IS; Krarup H; Thorlacius-Ussing O
Clin Epigenetics; 2016; 8():117. PubMed ID: 27891190
[TBL] [Abstract][Full Text] [Related]
2. Cell-free DNA promoter hypermethylation as a diagnostic marker for pancreatic ductal adenocarcinoma - An external validation study.
Henriksen SD; Stubbe BE; Madsen PH; Johansen JS; Jensen BV; Hansen CP; Johansen MN; Pedersen IS; Krarup H; Thorlacius-Ussing O
Pancreatology; 2021 May; ():. PubMed ID: 33994313
[TBL] [Abstract][Full Text] [Related]
3. Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer.
Ying L; Sharma A; Chhoda A; Ruzgar N; Hasan N; Kwak R; Wolfgang CL; Wang TH; Kunstman JW; Salem RR; Wood LD; Iacobuzio-Donahue C; Schneider EB; Farrell JJ; Ahuja N
Pancreas; 2021 Oct; 50(9):1267-1273. PubMed ID: 34860810
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma.
Stubbe BE; Madsen PH; Larsen AC; Krarup HB; Pedersen IS; Hansen CP; Johansen JS; Henriksen SD; Thorlacius-Ussing O
Pancreatology; 2023 Aug; 23(5):512-521. PubMed ID: 37230892
[TBL] [Abstract][Full Text] [Related]
5. Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer.
García-Ortiz MV; Cano-Ramírez P; Toledano-Fonseca M; Cano MT; Inga-Saavedra E; Rodríguez-Alonso RM; Guil-Luna S; Gómez-España MA; Rodríguez-Ariza A; Aranda E
Clin Epigenetics; 2023 Jul; 15(1):118. PubMed ID: 37481552
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer.
Xin W; Tu S; Yi S; Xiong Y; Fang K; Sun G; Xiao W
Gene; 2024 Mar; 897():148078. PubMed ID: 38097094
[TBL] [Abstract][Full Text] [Related]
7. New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.
Kisiel JB; Raimondo M; Taylor WR; Yab TC; Mahoney DW; Sun Z; Middha S; Baheti S; Zou H; Smyrk TC; Boardman LA; Petersen GM; Ahlquist DA
Clin Cancer Res; 2015 Oct; 21(19):4473-81. PubMed ID: 26023084
[TBL] [Abstract][Full Text] [Related]
8. DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma.
Wu Y; Seufert I; Al-Shaheri FN; Kurilov R; Bauer AS; Manoochehri M; Moskalev EA; Brors B; Tjaden C; Giese NA; Hackert T; Büchler MW; Hoheisel JD
Gut; 2023 Nov; 72(12):2344-2353. PubMed ID: 37709492
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases.
Draškovič T; Hauptman N
Sci Rep; 2024 Feb; 14(1):3095. PubMed ID: 38326602
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas.
Guo M; Jia Y; Yu Z; House MG; Esteller M; Brock MV; Herman JG
Discov Med; 2014 Feb; 17(92):67-73. PubMed ID: 24534469
[TBL] [Abstract][Full Text] [Related]
11. Precision oncology: Artificial intelligence, circulating cell-free DNA, and the minimally invasive detection of pancreatic cancer-A pilot study.
Bahado-Singh RO; Turkoglu O; Aydas B; Vishweswaraiah S
Cancer Med; 2023 Oct; 12(19):19644-19655. PubMed ID: 37787018
[TBL] [Abstract][Full Text] [Related]
12. Serum HSP70: a novel biomarker for early detection of pancreatic cancer.
Dutta SK; Girotra M; Singla M; Dutta A; Otis Stephen F; Nair PP; Merchant NB
Pancreas; 2012 May; 41(4):530-4. PubMed ID: 22158074
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing Gastric/Esophageal Adenocarcinoma from Pancreatic Adenocarcinoma Using Methylation-Based Droplet Digital PCR.
Xia D; Nowak K; Leon AJ; Winegarden N; Wong A; Boruvka N; Diamandis P; Chetty R; Pugh T; Zhang T; Aldape K; Stockley T; Serra S
Lab Invest; 2023 Jul; 103(7):100145. PubMed ID: 37004911
[TBL] [Abstract][Full Text] [Related]
14. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.
Campa D; Rizzato C; Capurso G; Giese N; Funel N; Greenhalf W; Soucek P; Gazouli M; Pezzilli R; Pasquali C; Talar-Wojnarowska R; Cantore M; Andriulli A; Scarpa A; Jamroziak K; Delle Fave G; Costello E; Khaw KT; Heller A; Key TJ; Theodoropoulos G; Malecka-Panas E; Mambrini A; Bambi F; Landi S; Pedrazzoli S; Bassi C; Pacetti P; Piepoli A; Tavano F; di Sebastiano P; Vodickova L; Basso D; Plebani M; Fogar P; Büchler MW; Bugert P; Vodicka P; Boggi U; Neoptolemos JP; Werner J; Canzian F
Dig Liver Dis; 2013 Feb; 45(2):95-9. PubMed ID: 23206934
[TBL] [Abstract][Full Text] [Related]
15. The high FKBP1A expression in WBCs as a potential screening biomarker for pancreatic cancer.
Watcharanurak P; Mutirangura A; Aksornkitti V; Bhummaphan N; Puttipanyalears C
Sci Rep; 2024 Apr; 14(1):7888. PubMed ID: 38570626
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of
Oh TJ; Jang S; Kim SJ; Woo MA; Son JW; Jeong IB; Lee MH; An S
Oncol Lett; 2024 Jun; 27(6):246. PubMed ID: 38638845
[TBL] [Abstract][Full Text] [Related]
17. Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA.
Haan D; Bergamaschi A; Friedl V; Guler GD; Ning Y; Reggiardo R; Kesling M; Collins M; Gibb B; Hazen K; Bates S; Antoine M; Fraire C; Lopez V; Malta R; Nabiyouni M; Nguyen A; Phillips T; Riviere M; Leighton A; Ellison C; McCarthy E; Scott A; Gigliotti L; Nilson E; Sheard J; Peters M; Bethel K; Chowdhury S; Volkmuth W; Levy S
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1802-1809.e6. PubMed ID: 36967102
[TBL] [Abstract][Full Text] [Related]
18. GLAD-PCR Assay of R(5mC)GY Sites in the Regulatory Region of Tumor-Suppressor Genes Associated with Gastric Cancer.
Malyshev BS; Netesova NA; Smetannikova NA; Abdurashitov MA; Akishev AG; Dubinin EV; Azanov AZ; Vihlyanov IV; Nikitin MK; Karpov AB; Degtyarev SK
Acta Naturae; 2020; 12(3):124-133. PubMed ID: 33173602
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Al-Bazy SA; Werge MP; Gluud LL; Therkildsen C; Novovic S
Ugeskr Laeger; 2023 Jun; 185(23):. PubMed ID: 37325980
[TBL] [Abstract][Full Text] [Related]
20. Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma.
Thompson JK; Bednar F
Epigenomes; 2021 Sep; 5(4):. PubMed ID: 34968245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
